Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-025-03776-7
Affiliations:
6
Authors:
18
Go to article
Institutions Authors Share
Fudan University Shanghai Cancer Center (FUSCC), China
8.750000
 0.49
Fudan University, China
8.000000
 0.44
Shanghai Key Laboratory of Medical Epigenetics, Fudan University, China
1.000000
 0.06
Shanghai Academy of Natural Sciences (SANS), China
0.250000
 0.01
Interested in Oncology and Carcinogenesis?